Salarius Pharmaceuticals - 53 Year Dividend History | SLRX
Historical dividend payout and yield for Salarius Pharmaceuticals (SLRX) since 1971. The current TTM dividend payout for Salarius Pharmaceuticals (SLRX) as of May 14, 2024 is $0.00. The current dividend yield for Salarius Pharmaceuticals as of May 14, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Drug Manufacturing |
$0.002B |
$0.002B |
|
Salarius Pharmaceuticals Inc. is a clinical-stage oncology company. It develops therapies for the treatment of cancers. The company's lead candidate is Seclidemstat, which is in clinical development for the treatment of Ewing sarcoma, as well as advanced solid tumors, including prostate, breast, and ovarian cancers. Salarius Pharmaceuticals Inc., formerly known as Flex Pharma Inc., is based in Houston, Texas.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
